SEC ownership of CARLSMED, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001794546.

Comparable stake leader

B CAPITAL GROUP MANAGEMENT, L.P.

Disclosed value leader

B CAPITAL GROUP MANAGEMENT, L.P.

Comparable rows

50/50

Latest evidence

03 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
B CAPITAL GROUP MANAGEMENT, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
03 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001794546
Issuer location
Carlsbad, CA

Ownership snapshot

Top shareholders of CARLSMED, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
B CAPITAL GROUP MANAGEMEN...
Disclosed value leader
B CAPITAL GROUP MANAGEMEN...
Comparable rows
50/50
Latest evidence
03 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 28% 13D/G row: B CAPITAL GROUP MANAGEMENT, L.P. Showing 1-8 of 50 holder rows.

Quick read

B CAPITAL GROUP MANAGEMENT, L.P. leads the comparable SEC ownership view at 28%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens B CAPITAL GROUP MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
B CAPITAL GROUP MANAGEMENT, L.P. 28%
Presidio Management Group XII, L.... 22%
Michael Cordonnier 5.9%
Jonathan D. Root 6.1%
Robert Mittendorff II 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
B CAPITAL GROUP MANAGEMENT, L.P.
3/4/5 13D/G
10%+ Owner
28%
from 13D/G
$120,665,564
8,321,763 shares
24 Jul 2025
Presidio Management Group XII, L.L.C.
13D/G 3/4/5
Casey M Tansey · 10%+ Owner
22%
$78,225,357
5,842,073 shares
$0 24 Jul 2025
Michael Cordonnier
3/4/5 13D/G
CEO, President, Director
5.9%
from 13D/G
$18,683,247
2,468,404 shares
mixed-class rows
-$2,629,889 02 Mar 2026
Jonathan D. Root
3/4/5
Director
6.1%
$14,619,731
1,615,440 shares
03 Jun 2026
Robert Mittendorff II
3/4/5
Director
3.5%
$13,506,054
931,452 shares
24 Jul 2025
Philip M. Young
3/4/5
Director
0.32%
$763,493
84,364 shares
03 Jun 2026
Kevin Sidow
3/4/5
Director
0.28%
$663,039
73,264 shares
03 Jun 2026
Kevin C. Oboyle
3/4/5
Director
0.12%
$280,830
31,031 shares
03 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$2,629,889.

Buys
$0
Insiders: 0
Sells
$2,629,889
Insiders: 1
Net
-$2,629,889
Shares: -197,855
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 197,855
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 197,855 $0 $2,629,889 -$2,629,889
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-11 of 11 reporting-owner rows connected to CARLSMED, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
11
Largest Forms 3/4/5 holder
B CAPITAL GROUP MANAGEMENT, L.P.
Net 12M change
-$2,629,889
Latest report
03 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
B CAPITAL GROUP MANAGEMENT, L.P. 10%+ Owner $120,665,564 Mixed 24 Jul 2025
Michael Cordonnier CEO, President, Director $18,683,247 -$2,629,889 -12% Mixed 02 Mar 2026
Presidio Management Group XII, L.L.C. 10%+ Owner $16,207,274 Mixed 24 Jul 2025
Jonathan D. Root Director $14,619,731 Mixed 03 Jun 2026
Robert Mittendorff II Director $13,506,054 Mixed 24 Jul 2025
Niall Casey Chief IP Officer, Director $12,282,025 Mixed 28 Jan 2026
Leonard M. Greenstein CFO, Treasurer $2,354,325 Mixed 28 Jan 2026
Philip M. Young Director $763,493 Mixed 03 Jun 2026
Kevin Sidow Director $663,039 Mixed 03 Jun 2026
William Scott Durall Chief Commercial Officer $562,212 Mixed 28 Jan 2026
Kevin C. Oboyle Director $280,830 Mixed 03 Jun 2026

Recent insider transactions for CARLSMED, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Kevin C. Oboyle CARL Common Stock Award 79% 13,698 31,031 03 Jun 2026 Direct
Kevin Sidow CARL Common Stock Award 23% 13,698 73,264 03 Jun 2026 Direct
Jonathan D. Root CARL Common Stock Award 2.83% 13,698 497,697 03 Jun 2026 Direct
Philip M. Young CARL Common Stock Award 79% 13,698 31,031 03 Jun 2026 Direct
Michael Cordonnier CARL Common Stock Options Exercise 14.3% 193,831 1,550,477 03 Mar 2026 Direct
Michael Cordonnier CARL Stock Option (Right to Buy) Options Exercise -100% -193,831 0 03 Mar 2026 Direct
Michael Cordonnier CARL Common Stock Sale -12.7% $2,629,889 $13.29 -197,855 1,356,646 02 Mar 2026 Direct
Michael Cordonnier CARL Common Stock Options Exercise 14.6% 197,855 1,554,501 02 Mar 2026 Direct
Michael Cordonnier CARL Stock Option (Right to Buy) Options Exercise -55.2% -197,855 160,567 02 Mar 2026 Direct
William Scott Durall CARL Common Stock Award 44,977 44,977 28 Jan 2026 Direct
Niall Casey CARL Common Stock Award 4.8% 44,977 982,562 28 Jan 2026 Direct
Michael Cordonnier CARL Common Stock Award 9.47% 117,316 1,356,646 28 Jan 2026 Direct
Leonard M. Greenstein CARL Common Stock Award 31.4% 44,977 188,346 28 Jan 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .